Fulfilling Paul Ehrlich’s Dream: therapeutics with activity on demand

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Protease-Cleavable Linkers Modulate the Anticancer Activity of Noninternalizing Antibody–Drug Conjugates

Author(s): Alberto Dal Corso, Samuele Cazzamalli, Rémy Gébleux, Martin Mattarella, Dario Neri
Published in: Bioconjugate Chemistry, Issue 28/7, 2017, Page(s) 1826-1833, ISSN 1043-1802
Publisher: American Chemical Society
DOI: 10.1021/acs.bioconjchem.7b00304

A Specific and Covalent JNK-1 Ligand Selected from an Encoded Self-Assembling Chemical Library

Author(s): Gunther Zimmermann, Ulrike Rieder, Davor Bajic, Sara Vanetti, Apirat Chaikuad, Stefan Knapp, Jörg Scheuermann, Martin Mattarella, Dario Neri
Published in: Chemistry - A European Journal, Issue 23/34, 2017, Page(s) 8152-8155, ISSN 0947-6539
Publisher: John Wiley & Sons Ltd.
DOI: 10.1002/chem.201701644

DNA-Encoded Chemical Libraries: A Selection System Based On Endowing Organic Compounds with Amplifiable Information

Author(s): Dario Neri, Richard A. Lerner
Published in: Annual Review of Biochemistry, Issue 87/1, 2018, ISSN 0066-4154
Publisher: Annual Reviews, Inc.
DOI: 10.1146/annurev-biochem-062917-012550

Sarcoma Eradication by Doxorubicin and Targeted TNF Relies upon CD8 + T-cell Recognition of a Retroviral Antigen

Author(s): Philipp Probst, Janine Kopp, Annette Oxenius, Mario P. Colombo, Danilo Ritz, Tim Fugmann, Dario Neri
Published in: Cancer Research, Issue 77/13, 2017, Page(s) 3644-3654, ISSN 0008-5472
Publisher: American Association for Cancer Research
DOI: 10.1158/0008-5472.CAN-16-2946

A non-internalizing antibody-drug conjugate based on an anthracycline payload displays potent therapeutic activity in vivo

Author(s): Alberto Dal Corso, Rémy Gébleux, Patrizia Murer, Alex Soltermann, Dario Neri
Published in: Journal of Controlled Release, Issue 264, 2017, Page(s) 211-218, ISSN 0168-3659
Publisher: Elsevier BV
DOI: 10.1016/j.jconrel.2017.08.040

Intratumoral administration of IL2- and TNF-based fusion proteins cures cancer without establishing protective immunity

Author(s): Barbara Ziffels, Francesca Pretto, Dario Neri
Published in: Immunotherapy, Issue 10/3, 2018, Page(s) 177-188, ISSN 1750-743X
Publisher: Future Medicine Ltd.
DOI: 10.2217/imt-2017-0119

Potency-matched Dual Cytokine–Antibody Fusion Proteins for Cancer Therapy

Author(s): Roberto De Luca, Alex Soltermann, Francesca Pretto, Catherine Pemberton-Ross, Giovanni Pellegrini, Sarah Wulhfard, Dario Neri
Published in: Molecular Cancer Therapeutics, Issue 16/11, 2017, Page(s) 2442-2451, ISSN 1535-7163
Publisher: American Association for Cancer Research
DOI: 10.1158/1535-7163.MCT-17-0211

Antibody-based targeted delivery of interleukin-4 synergizes with dexamethasone for the reduction of inflammation in arthritis

Author(s): Anja Sophie Schmid, Teresa Hemmerle, Francesca Pretto, Anja Kipar, Dario Neri
Published in: Rheumatology, 2018, ISSN 1462-0324
Publisher: Oxford University Press
DOI: 10.1093/rheumatology/kex447

Data-Independent Acquisition of HLA Class I Peptidomes on the Q Exactive Mass Spectrometer Platform

Author(s): Danilo Ritz, Jonny Kinzi, Dario Neri, Tim Fugmann
Published in: PROTEOMICS, Issue 17/19, 2017, Page(s) 1700177, ISSN 1615-9853
Publisher: John Wiley & Sons Ltd.
DOI: 10.1002/pmic.201700177

Chemically Defined Antibody– and Small Molecule–Drug Conjugates for in Vivo Tumor Targeting Applications: A Comparative Analysis

Author(s): Samuele Cazzamalli, Alberto Dal Corso, Fontaine Widmayer, Dario Neri
Published in: Journal of the American Chemical Society, Issue 140/5, 2018, Page(s) 1617-1621, ISSN 0002-7863
Publisher: American Chemical Society
DOI: 10.1021/jacs.7b13361

Novel antibody-cytokine fusion proteins featuring granulocyte-colony stimulating factor, interleukin-3 and interleukin-4 as payloads

Author(s): Anja Sophie Schmid, Diana Tintor, Dario Neri
Published in: Journal of Biotechnology, Issue 271, 2018, Page(s) 29-36, ISSN 0168-1656
Publisher: Elsevier BV
DOI: 10.1016/j.jbiotec.2018.02.004

Membranal and blood-soluble HLA class II peptidome analyses using data-dependent and independent acquisition

Author(s): Danilo Ritz, Emiliano Sani, Hanna Debiec, Pierre Ronco, Dario Neri, Tim Fugmann
Published in: PROTEOMICS, 2018, ISSN 1615-9853
Publisher: John Wiley & Sons Ltd.
DOI: 10.1002/pmic.201700246

Targeted Delivery of Cytotoxic Drugs: Challenges, Opportunities and New Developments

Author(s): Samuele Cazzamalli, Alberto Dal Corso, Dario Neri
Published in: CHIMIA International Journal for Chemistry, Issue 71/10, 2017, Page(s) 712-715, ISSN 0009-4293
Publisher: Schweizerische Chemische Gedellschaft
DOI: 10.2533/chimia.2017.712

Versatile protein recognition by the encoded display of multiple chemical elements on a constant macrocyclic scaffold

Author(s): Yizhou Li, Roberto De Luca, Samuele Cazzamalli, Francesca Pretto, Davor Bajic, Jörg Scheuermann, Dario Neri
Published in: Nature Chemistry, Issue 10/4, 2018, Page(s) 441-448, ISSN 1755-4330
Publisher: Nature Publishing Group
DOI: 10.1038/s41557-018-0017-8

DNA-encoded chemical libraries - achievements and remaining challenges

Author(s): Nicholas Favalli, Gabriele Bassi, Jörg Scheuermann, Dario Neri
Published in: FEBS Letters, Issue 592/12, 2018, Page(s) 2168-2180, ISSN 0014-5793
Publisher: Elsevier BV
DOI: 10.1002/1873-3468.13068

A DNA-Encoded Library of Chemical Compounds Based on Common Scaffolding Structures Reveals the Impact of Ligand Geometry on Protein Recognition

Author(s): Nicholas Favalli, Stefan Biendl, Marco Hartmann, Jacopo Piazzi, Filippo Sladojevich, Susanne Gräslund, Peter J. Brown, Katja Näreoja, Herwig Schüler, Jörg Scheuermann, Raphael Franzini, Dario Neri
Published in: ChemMedChem, Issue 13/13, 2018, Page(s) 1303-1307, ISSN 1860-7179
Publisher: Wiley - V C H Verlag GmbbH & Co.
DOI: 10.1002/cmdc.201800193

Enhanced Therapeutic Activity of Non-Internalizing Small-Molecule-Drug Conjugates Targeting Carbonic Anhydrase IX in Combination with Targeted Interleukin-2

Author(s): Samuele Cazzamalli, Barbara Ziffels, Fontaine Widmayer, Patrizia Murer, Giovanni Pellegrini, Francesca Pretto, Sarah Wulhfard, Dario Neri
Published in: Clinical Cancer Research, Issue 24/15, 2018, Page(s) 3656-3667, ISSN 1078-0432
Publisher: American Association for Cancer Research
DOI: 10.1158/1078-0432.CCR-17-3457

DNA-encoded chemical libraries: foundations and applications in lead discovery

Author(s): Gunther Zimmermann, Dario Neri
Published in: Drug Discovery Today, Issue 21/11, 2016, Page(s) 1828-1834, ISSN 1359-6446
Publisher: Elsevier BV
DOI: 10.1016/j.drudis.2016.07.013

Purification of soluble HLA class I complexes from human serum or plasma deliver high quality immuno peptidomes required for biomarker discovery

Author(s): Danilo Ritz, Andreas Gloger, Dario Neri, Tim Fugmann
Published in: PROTEOMICS, Issue 17/1-2, 2017, Page(s) 1600364, ISSN 1615-9853
Publisher: John Wiley & Sons Ltd.
DOI: 10.1002/pmic.201600364

Different tissue distribution properties for glycosylation variants of fusion proteins containing the p40 subunit of murine interleukin-12

Author(s): F. Bootz, D. Venetz, B. Ziffels, D. Neri
Published in: Protein Engineering Design and Selection, Issue 29/10, 2016, Page(s) 445-455, ISSN 1741-0126
Publisher: Oxford University Press
DOI: 10.1093/protein/gzw038

Acetazolamide Serves as Selective Delivery Vehicle for Dipeptide-Linked Drugs to Renal Cell Carcinoma

Author(s): Samuele Cazzamalli, Alberto Dal Corso, Dario Neri
Published in: Molecular Cancer Therapeutics, Issue 15/12, 2016, Page(s) 2926-2935, ISSN 1535-7163
Publisher: American Association for Cancer Research
DOI: 10.1158/1535-7163.MCT-16-0283

Mass spectrometric analysis of the HLA class I peptidome of melanoma cell lines as a promising tool for the identification of putative tumor-associated HLA epitopes

Author(s): Andreas Gloger, Danilo Ritz, Tim Fugmann, Dario Neri
Published in: Cancer Immunology, Immunotherapy, Issue 65/11, 2016, Page(s) 1377-1393, ISSN 0340-7004
Publisher: Springer Verlag
DOI: 10.1007/s00262-016-1897-3

Targeted Reconstitution of Cytokine Activity upon Antigen Binding using Split Cytokine Antibody Fusion Proteins

Author(s): Dario Venetz, Danil Koovely, Bruce Weder, Dario Neri
Published in: Journal of Biological Chemistry, Issue 291/35, 2016, Page(s) 18139-18147, ISSN 0021-9258
Publisher: American Society for Biochemistry and Molecular Biology Inc.
DOI: 10.1074/jbc.M116.737734

Optimized Reaction Conditions for Amide Bond Formation in DNA-Encoded Combinatorial Libraries

Author(s): Yizhou Li, Elena Gabriele, Florent Samain, Nicholas Favalli, Filippo Sladojevich, Jörg Scheuermann, Dario Neri
Published in: ACS Combinatorial Science, Issue 18/8, 2016, Page(s) 438-443, ISSN 2156-8952
Publisher: American Chemical Society
DOI: 10.1021/acscombsci.6b00058

Linker stability influences the anti-tumor activity of acetazolamide-drug conjugates for the therapy of renal cell carcinoma

Author(s): Samuele Cazzamalli, Alberto Dal Corso, Dario Neri
Published in: Journal of Controlled Release, Issue 246, 2017, Page(s) 39-45, ISSN 0168-3659
Publisher: Elsevier BV
DOI: 10.1016/j.jconrel.2016.11.023

Non-internalizing antibody-drug conjugates display potent anti-cancer activity upon proteolytic release of monomethyl auristatin E in the subendothelial extracellular matrix

Author(s): Rémy Gébleux, Marco Stringhini, Ruben Casanova, Alex Soltermann, Dario Neri
Published in: International Journal of Cancer, Issue 140/7, 2017, Page(s) 1670-1679, ISSN 0020-7136
Publisher: John Wiley & Sons Inc.
DOI: 10.1002/ijc.30569

The MHC Class II Immunopeptidome of Lymph Nodes in Health and in Chemically Induced Colitis

Author(s): Tim Fugmann, Adriana Sofron, Danilo Ritz, Franziska Bootz, Dario Neri
Published in: The Journal of Immunology, Issue 198/3, 2017, Page(s) 1357-1364, ISSN 0022-1767
Publisher: American Association of Immunologists
DOI: 10.4049/jimmunol.1601157

Intralesional treatment of metastatic melanoma: a review of therapeutic options

Author(s): Benjamin Weide, Dario Neri, Giuliano Elia
Published in: Cancer Immunology, Immunotherapy, 2017, ISSN 0340-7004
Publisher: Springer Verlag
DOI: 10.1007/s00262-016-1952-0

Hit-Validation Methodologies for Ligands Isolated from DNA-Encoded Chemical Libraries

Author(s): Gunther Zimmermann, Yizhou Li, Ulrike Rieder, Martin Mattarella, Dario Neri, Jörg Scheuermann
Published in: ChemBioChem, 2017, ISSN 1439-4227
Publisher: John Wiley & Sons Ltd.
DOI: 10.1002/cbic.201600637

Quantitative PCR is a Valuable Tool to Monitor the Performance of DNA-Encoded Chemical Library Selections

Author(s): Yizhou Li, Gunther Zimmermann, Jörg Scheuermann, Dario Neri
Published in: ChemBioChem, 2017, ISSN 1439-4227
Publisher: John Wiley & Sons Ltd.
DOI: 10.1002/cbic.201600626

A novel dual-cytokine–antibody fusion protein for the treatment of CD38-positive malignancies

Author(s): Roberto De Luca, Paul Kachel, Klara Kropivsek, Berend Snijder, Markus G Manz, Dario Neri
Published in: Protein Engineering, Design and Selection, Issue 31/5, 2018, Page(s) 173-179, ISSN 1741-0126
Publisher: Oxford University Press
DOI: 10.1093/protein/gzy015

Antibody-based Delivery of TNF to the Tumor Neovasculature Potentiates the Therapeutic Activity of a Peptide Anticancer Vaccine

Author(s): Philipp Probst, Marco Stringhini, Danilo Ritz, Tim Fugmann, Dario Neri
Published in: Clinical Cancer Research, Issue 25/2, 2019, Page(s) 698-709, ISSN 1078-0432
Publisher: American Association for Cancer Research
DOI: 10.1158/1078-0432.CCR-18-1728

Antibody-mediated delivery of VEGF-C potently reduces chronic skin inflammation

Author(s): Simon Schwager, Silvana Renner, Teresa Hemmerle, Sinem Karaman, Steven T. Proulx, Roman Fetz, Alexandra Michaela Golding-Ochsenbein, Philipp Probst, Cornelia Halin, Dario Neri, Michael Detmar
Published in: JCI Insight, Issue 3/23, 2018, ISSN 2379-3708
Publisher: The American Society for Clinical Investigation
DOI: 10.1172/jci.insight.124850

A Novel Fully-Human Potency-Matched Dual Cytokine-Antibody Fusion Protein Targets Carbonic Anhydrase IX in Renal Cell Carcinomas

Author(s): Roberto De Luca, Baptiste Gouyou, Tiziano Ongaro, Alessandra Villa, Barbara Ziffels, Alessandro Sannino, Gianluca Buttinoni, Simone Galeazzi, Mirko Mazzacuva, Dario Neri
Published in: Frontiers in Oncology, Issue 9, 2019, ISSN 2234-943X
Publisher: Frontiers Media S. A.
DOI: 10.3389/fonc.2019.01228

Development of a novel fully-human anti-CD123 antibody to target acute myeloid leukemia

Author(s): Cornelia Hutmacher, Laura Volta, Francesco Rinaldi, Patrizia Murer, Renier Myburgh, Markus G. Manz, Dario Neri
Published in: Leukemia Research, Issue 84, 2019, Page(s) 106178, ISSN 0145-2126
Publisher: Pergamon Press Ltd.
DOI: 10.1016/j.leukres.2019.106178

Targeted Delivery of TNF Potentiates the Antibody-Dependent Cell-Mediated Cytotoxicity of an Anti-Melanoma Immunoglobulin

Author(s): Patrizia Murer, Jonathan D. Kiefer, Louis Plüss, Mattia Matasci, Sandra L. Blümich, Marco Stringhini, Dario Neri
Published in: Journal of Investigative Dermatology, Issue 139/6, 2019, Page(s) 1339-1348, ISSN 0022-202X
Publisher: Blackwell Publishing Inc.
DOI: 10.1016/j.jid.2018.11.028

Antibody-cytokine fusion proteins: A novel class of biopharmaceuticals for the therapy of cancer and of chronic inflammation

Author(s): Patrizia Murer, Dario Neri
Published in: New Biotechnology, Issue 52, 2019, Page(s) 42-53, ISSN 1871-6784
Publisher: Elsevier BV
DOI: 10.1016/j.nbt.2019.04.002

Antibody-Based Delivery of Cytokine Payloads to Carbonic Anhydrase IX Leads to Cancer Cures in Immunocompetent Tumor-Bearing Mice

Author(s): Barbara Ziffels, Marco Stringhini, Philipp Probst, Tim Fugmann, Theo Sturm, Dario Neri
Published in: Molecular Cancer Therapeutics, Issue 18/9, 2019, Page(s) 1544-1554, ISSN 1535-7163
Publisher: American Association for Cancer Research
DOI: 10.1158/1535-7163.mct-18-1301

In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas

Author(s): Cazzamalli, Samuele; Figueras, Eduard; Pethő, Lilla; Borbély, Adina; Steinkühler, Christian; Neri, Dario; Sewald, Norbert
Published in: ACS Omega, 3 (11), Issue 1, 2018, Page(s) 14726-14731, ISSN 2470-1343
Publisher: American Chemistry Society
DOI: 10.3929/ethz-b-000304161

Potentiation of PD-L1 blockade with a potency-matched dual cytokine–antibody fusion protein leads to cancer eradication in BALB/c-derived tumors but not in other mouse strains

Author(s): Roberto De Luca, Dario Neri
Published in: Cancer Immunology, Immunotherapy, Issue 67/9, 2018, Page(s) 1381-1391, ISSN 0340-7004
Publisher: Springer Verlag
DOI: 10.1007/s00262-018-2194-0

Design and characterisation of a novel interleukin-15 receptor alpha fusion protein and analysis of interleukin-15 complexation

Author(s): Anja Sophie Schmid, Dario Neri
Published in: PLOS ONE, Issue 14/7, 2019, Page(s) e0219313, ISSN 1932-6203
Publisher: Public Library of Science
DOI: 10.1371/journal.pone.0219313

DNA-Compatible Diazo-Transfer Reaction in Aqueous Media Suitable for DNA-Encoded Chemical Library Synthesis

Author(s): Adrián Gironda-Martínez, Dario Neri, Florent Samain, Etienne J. Donckele
Published in: Organic Letters, Issue 21/23, 2019, Page(s) 9555-9558, ISSN 1523-7060
Publisher: American Chemical Society
DOI: 10.1021/acs.orglett.9b03726

Comparative evaluation of bolus and fractionated administration modalities for two antibody-cytokine fusions in immunocompetent tumor-bearing mice

Author(s): Emanuele Puca, Roberto De Luca, Frauke Seehusen, Josep Maria Monné Rodriguez, Dario Neri
Published in: Journal of Controlled Release, 2019, ISSN 0168-3659
Publisher: Elsevier BV
DOI: 10.1016/j.jconrel.2019.11.036

The antibody‐based delivery of interleukin‐12 to solid tumors boosts NK and CD8 + T cell activity and synergizes with immune checkpoint inhibitors

Author(s): Emanuele Puca, Philipp Probst, Marco Stringhini, Patrizia Murer, Giovanni Pellegrini, Samuele Cazzamalli, Cornelia Hutmacher, Baptiste Gouyou, Sarah Wulhfard, Mattia Matasci, Alessandra Villa, Dario Neri
Published in: International Journal of Cancer, 2019, ISSN 0020-7136
Publisher: John Wiley & Sons Inc.
DOI: 10.1002/ijc.32603

Targeted enhancement of the therapeutic window of L19-TNF by transient and selective inhibition of RIPK1-signaling cascade

Author(s): Sheila Dakhel, Tiziano Ongaro, Baptiste Gouyou, Mattia Matasci, Alessandra Villa, Dario Neri, Samuele Cazzamalli
Published in: Oncotarget, Issue 10/62, 2019, ISSN 1949-2553
Publisher: Impact Journals
DOI: 10.18632/oncotarget.27320

Targeted Delivery of IL2 to the Tumor Stroma Potentiates the Action of Immune Checkpoint Inhibitors by Preferential Activation of NK and CD8 + T Cells

Author(s): Cornelia Hutmacher, Nicolás Gonzalo Núñez, Anna Rita Liuzzi, Burkhard Becher, Dario Neri
Published in: Cancer Immunology Research, Issue 7/4, 2019, Page(s) 572-583, ISSN 2326-6066
Publisher: American Association for Cancer Research Inc.
DOI: 10.1158/2326-6066.cir-18-0566

Antibody–Cytokine Fusions: Versatile Products for the Modulation of Anticancer Immunity

Author(s): Dario Neri
Published in: Cancer Immunology Research, Issue 7/3, 2019, Page(s) 348-354, ISSN 2326-6066
Publisher: American Association for Cancer Research Inc.
DOI: 10.1158/2326-6066.cir-18-0622

A fully human anti-IL-7Rα antibody promotes antitumor activity against T-cell acute lymphoblastic leukemia

Author(s): Padma Akkapeddi, Rita Fragoso, Julie A. Hixon, Ana Sofia Ramalho, Mariana L. Oliveira, Tânia Carvalho, Andreas Gloger, Mattia Matasci, Francisco Corzana, Scott K. Durum, Dario Neri, Gonçalo J. L. Bernardes, João T. Barata
Published in: Leukemia, Issue 33/9, 2019, Page(s) 2155-2168, ISSN 0887-6924
Publisher: Nature Publishing Group
DOI: 10.1038/s41375-019-0434-8

Immunocytokines and bispecific antibodies: two complementary strategies for the selective activation of immune cells at the tumor site

Author(s): Jonathan D. Kiefer, Dario Neri
Published in: Immunological Reviews, Issue 270/1, 2016, Page(s) 178-192, ISSN 0105-2896
Publisher: Blackwell Publishing Inc.
DOI: 10.1111/imr.12391

Antibody Format and Drug Release Rate Determine the Therapeutic Activity of Noninternalizing Antibody-Drug Conjugates

Author(s): R. Gebleux, S. Wulhfard, G. Casi, D. Neri
Published in: Molecular Cancer Therapeutics, Issue 14/11, 2015, Page(s) 2606-2612, ISSN 1535-7163
Publisher: American Association for Cancer Research
DOI: 10.1158/1535-7163.MCT-15-0480

Immunocytokines: a novel class of products for the treatment of chronic inflammation and autoimmune conditions

Author(s): Franziska Bootz, Dario Neri
Published in: Drug Discovery Today, Issue 21/1, 2016, Page(s) 180-189, ISSN 1359-6446
Publisher: Elsevier BV
DOI: 10.1016/j.drudis.2015.10.012

High-sensitivity HLA class I peptidome analysis enables a precise definition of peptide motifs and the identification of peptides from cell lines and patients’ sera

Author(s): Danilo Ritz, Andreas Gloger, Benjamin Weide, Claus Garbe, Dario Neri, Tim Fugmann
Published in: PROTEOMICS, 2016, Page(s) n/a-n/a, ISSN 1615-9853
Publisher: John Wiley & Sons Ltd.
DOI: 10.1002/pmic.201500445

Immunocytokines for cancer treatment: past, present and future

Author(s): Dario Neri, Paul M Sondel
Published in: Current Opinion in Immunology, Issue 40, 2016, Page(s) 96-102, ISSN 0952-7915
Publisher: Elsevier BV
DOI: 10.1016/j.coi.2016.03.006

A universal reporter cell line for bioactivity evaluation of engineered cytokine products

Author(s): Jacqueline Mock, Christian Pellegrino, Dario Neri
Published in: Scientific Reports, Issue 10/1, 2020, ISSN 2045-2322
Publisher: Nature Publishing Group
DOI: 10.1038/s41598-020-60182-4

A novel human monoclonal antibody specific to the A33 glycoprotein recognizes colorectal cancer and inhibits metastasis

Author(s): Patrizia Murer, Louis Plüss, Dario Neri
Published in: mAbs, Issue 12/1, 2020, Page(s) 1714371, ISSN 1942-0870
Publisher: Landes Bioscience
DOI: 10.1080/19420862.2020.1714371

Searching for OpenAIRE data...

Publications

Share this page Share this page on social networks

Download Download the content of the page